StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Johnson & Johnson (JNJ) Ticks Off Lows on Analyst Defense
October 18, 2019 1:32 PM
Johnson & Johnson (NYSE: JNJ) ticks off lows ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Trader Talk
Next Articles
Actelion Pharmaceuticals Reports New OPSUMIT (macitentan) Data Show Initial Combination Therapy with Tadalafil Improved Hemodynamic Clinical & Functional Parameters in Patients with PAH
October 21, 2019 9:04 AM